TodkarS, PadwalR, MichaudA, CloutierL: Knowledge, perception and practice of health professionals regarding blood pressure measurement methods: A scoping review. J Hypertens39: 391–399, 2021PubMed
TodkarS, PadwalR, MichaudA, CloutierL: Knowledge, perception and practice of health professionals regarding blood pressure measurement methods: A scoping review. J Hypertens 39: 391–399, 2021PubMed10.1097/HJH.0000000000002663)| false
WheltonPK, CareyRM, AronowWS, CaseyJrDE, CollinsKJ, Dennison HimmelfarbC, et al.: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension71: e13–e115, 2018PubMed
WheltonPK, CareyRM, AronowWS, CaseyJrDE, CollinsKJ, Dennison HimmelfarbC, : 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71: e13–e115, 2018PubMed)| false
HayerR, KirleyK, CohenJB, TsipasS, SutherlandSE, OparilS, et al.: Using web-based training to improve accuracy of blood pressure measurement among health care professionals: A randomized trial. J Clin Hypertens (Greenwich)24: 255–262, 2022PubMed
HayerR, KirleyK, CohenJB, TsipasS, SutherlandSE, OparilS, : Using web-based training to improve accuracy of blood pressure measurement among health care professionals: A randomized trial. J Clin Hypertens (Greenwich) 24: 255–262, 2022PubMed10.1111/jch.14419)| false
KarioK: Management of hypertension in the digital era: Small wearable monitoring devices for remote blood pressure monitoring. Hypertension76: 640–650, 2020PubMed
KarioK: Management of hypertension in the digital era: Small wearable monitoring devices for remote blood pressure monitoring. Hypertension 76: 640–650, 2020PubMed10.1161/HYPERTENSIONAHA.120.14742)| false
MukkamalaR, YavarimaneshM, NatarajanK, HahnJO, KyriakoulisKG, AvolioAP, et al.: Evaluation of the accuracy of cuffless blood pressure measurement devices: Challenges and proposals. Hypertension78: 1161–1167, 2021PubMed
NachmanD, GepnerY, GoldsteinN, KabakovE, IshayAB, LittmanR, et al.: Comparing blood pressure measurements between a photoplethysmography-based and a standard cuff-based manometry device. Sci Rep10: 16116, 2020PubMed
ZachwiejaJ, Neyman-BartkowiakA, RabiegaA, WojciechowskaM, BarabaszM, MusielakA, et al.: Comparison of cuff-based and cuffless continuous blood pressure measurements in children and adolescents. Clin Exp Hypertens42: 512–518, 2020PubMed
MoharramMA, WilsonLC, WilliamsMJ, CoffeyS: Beat-to-beat blood pressure measurement using a cuffless device does not accurately reflect invasive blood pressure. Int J Cardiol Hypertens5: 100030, 2020PubMed
Cheung AK, Chang TI, Cushman WC, et al. Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int99: 559–569, 2021PubMed
Cheung AK, Chang TI, Cushman WC, et al. Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int99: 559–569, 2021PubMed10.1016/j.kint.2020.10.026)| false
TomsonCRV, CheungAK, MannJFE, ChangTI, CushmanWC, FurthSL, et al.: Management of blood pressure in patients with chronic kidney disease not receiving dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline. Ann Intern Med174: 1270–1281, 2021PubMed
TomsonCRV, CheungAK, MannJFE, ChangTI, CushmanWC, FurthSL, : Management of blood pressure in patients with chronic kidney disease not receiving dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline. Ann Intern Med 174: 1270–1281, 2021PubMed10.7326/M21-0834)| false
TobeSW, DubrofskyL, NasserDI, RajasinghamR, MyersMG: Randomized controlled trial comparing automated office blood pressure readings after zero or five minutes of rest. Hypertension78: 353–359, 2021PubMed
JuraschekSP, IshakAM, MukamalKJ, WoodJM, AndersonTS, CohenML, et al.: Impact of 30- versus 60-second time intervals between automated office blood pressure measurements on measured blood pressure. Hypertension78: 1502–1510, 2021PubMed
National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. JAMA237: 255–261, 1977PubMed
National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. JAMA 237: 255–261, 1977PubMed10.1001/jama.1977.03270300059008)| false
LeeH, YanoY, ChoSMJ, ParkJH, ParkS, Lloyd-JonesDM, et al.: Cardiovascular risk of isolated systolic or diastolic hypertension in young adults. Circulation141: 1778–1786, 2020PubMed
Vishram-NielsenJKK, KristensenAMD, PareekM, LaurentS, NilssonPM, LinnebergA, et al.: Predictive importance of blood pressure characteristics with increasing age in healthy men and women: The MORGAM project. Hypertension77: 1076–1085, 2021PubMed
Vishram-NielsenJKK, KristensenAMD, PareekM, LaurentS, NilssonPM, LinnebergA, : Predictive importance of blood pressure characteristics with increasing age in healthy men and women: The MORGAM project. Hypertension 77: 1076–1085, 2021PubMed10.1161/HYPERTENSIONAHA.120.16354)| false
McEvoyJW, YangWY, ThijsL, ZhangZY, MelgarejoJD, BoggiaJ, et al.; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators: Isolated diastolic hypertension in the IDACO study: An age-stratified analysis using 24-hour ambulatory blood pressure measurements. Hypertension78: 1222–1231, 2021PubMed
LiY, ThijsL, HansenTW, KikuyaM, BoggiaJ, RichartT, et al.; International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Investigators: Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension55: 1040–1048, 2010PubMed
LiY, ThijsL, HansenTW, KikuyaM, BoggiaJ, RichartT, ; International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Investigators: Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension 55: 1040–1048, 2010PubMed10.1161/HYPERTENSIONAHA.109.137273)| false
WilliamsB, ManciaG, SpieringW, Agabiti RoseiE, AziziM, BurnierM, et al.; Authors/Task Force Members: 2018 ESC/ESH Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens36: 1953–2041, 2018PubMed
WilliamsB, ManciaG, SpieringW, Agabiti RoseiE, AziziM, BurnierM, ; Authors/Task Force Members: 2018 ESC/ESH Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 36: 1953–2041, 2018PubMed)| false
SalazarMR, EspecheWG, BalbínE, Leiva SisnieguezCE, MinettoJ, Leiva SisnieguezBC, et al.: Prevalence of isolated nocturnal hypertension according to 2018 European Society of Cardiology and European Society of Hypertension office blood pressure categories. J Hypertens38: 434–440, 2020PubMed
SalazarMR, EspecheWG, BalbínE, Leiva SisnieguezCE, MinettoJ, Leiva SisnieguezBC, : Prevalence of isolated nocturnal hypertension according to 2018 European Society of Cardiology and European Society of Hypertension office blood pressure categories. J Hypertens 38: 434–440, 2020PubMed10.1097/HJH.0000000000002278)| false
CoccinaF, PierdomenicoAM, CuccurulloC, PizzicannellaJ, MadonnaR, TrubianiO, et al.: Prognostic Value of Masked Uncontrolled Hypertension Defined by Different Ambulatory Blood Pressure Criteria. Am J Hypertens33: 726–733, 2020PubMed
CoccinaF, PierdomenicoAM, CuccurulloC, PizzicannellaJ, MadonnaR, TrubianiO, : Prognostic Value of Masked Uncontrolled Hypertension Defined by Different Ambulatory Blood Pressure Criteria. Am J Hypertens 33: 726–733, 2020PubMed10.1093/ajh/hpaa078)| false
FujiwaraT, HoshideS, KanegaeH, KarioK: Prognostic value of a riser pattern of nighttime blood pressure in very elderly adults of ≥80 years: A general practice-based prospective SEARCH study. Am J Hypertens33: 520–527, 2020PubMed
FujiwaraT, HoshideS, KanegaeH, KarioK: Prognostic value of a riser pattern of nighttime blood pressure in very elderly adults of ≥80 years: A general practice-based prospective SEARCH study. Am J Hypertens 33: 520–527, 2020PubMed10.1093/ajh/hpz197)| false
EganBM, LiJ, SutherlandSE, RakotzMK, WozniakGD: Hypertension control in the United States 2009 to 2018: Factors underlying falling control rates during 2015 to 2018 across age- and race-ethnicity groups. Hypertension78: 578–587, 2021PubMed
EganBM, LiJ, SutherlandSE, RakotzMK, WozniakGD: Hypertension control in the United States 2009 to 2018: Factors underlying falling control rates during 2015 to 2018 across age- and race-ethnicity groups. Hypertension 78: 578–587, 2021PubMed10.1161/HYPERTENSIONAHA.120.16418)| false
FlackJM: Better implementation of what is known will reverse falling hypertension control rates: We know how to reverse falling hypertension rates. Hypertension78: 588–590, 2021PubMed
FlackJM: Better implementation of what is known will reverse falling hypertension control rates: We know how to reverse falling hypertension rates. Hypertension 78: 588–590, 2021PubMed10.1161/HYPERTENSIONAHA.121.17512)| false
FataniN, DixonDL, Van TassellBW, FanikosJ, BuckleyLF: Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension. J Am Coll Cardiol77: 1290–1299, 2021PubMed
FataniN, DixonDL, Van TassellBW, FanikosJ, BuckleyLF: Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension. J Am Coll Cardiol 77: 1290–1299, 2021PubMed10.1016/j.jacc.2021.01.014)| false
CarterBL, CoffeyCS, ArderyG, UribeL, EcklundD, JamesP, et al.: Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes8: 235–243, 2015PubMed
DixonDL, BakerWL, BuckleyLF, SalgadoTM, Van TassellBW, CarterBL: Effect of a physician/pharmacist collaborative care model on time in target range for systolic blood pressure: Post hoc analysis of the CAPTION trial. Hypertension78: 966–972, 2021PubMed
DixonDL, BakerWL, BuckleyLF, SalgadoTM, Van TassellBW, CarterBL: Effect of a physician/pharmacist collaborative care model on time in target range for systolic blood pressure: Post hoc analysis of the CAPTION trial. Hypertension 78: 966–972, 2021PubMed10.1161/HYPERTENSIONAHA.121.17873)| false
DuZ, XingL, YeN, LinM, SunY: Complementary value of ECG and echocardiographic left ventricular hypertrophy for prediction of adverse outcomes in the general population. J Hypertens39: 548–555, 2021PubMed
DuZ, XingL, YeN, LinM, SunY: Complementary value of ECG and echocardiographic left ventricular hypertrophy for prediction of adverse outcomes in the general population. J Hypertens 39: 548–555, 2021PubMed10.1097/HJH.0000000000002652)| false
NealB, WuY, FengX, ZhangR, ZhangY, ShiJ, et al.: Effect of salt substitution on cardiovascular events and death. N Engl J Med385: 1067–1077, 2021PubMed
NealB, WuY, FengX, ZhangR, ZhangY, ShiJ, : Effect of salt substitution on cardiovascular events and death. N Engl J Med 385: 1067–1077, 2021PubMed10.1056/NEJMoa2105675)| false
MoralesDR, PacurariuA, SlatteryJ, KurzX: Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies. Br J Clin Pharmacol86: 1336–1345, 2020PubMed
MoralesDR, PacurariuA, SlatteryJ, KurzX: Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies. Br J Clin Pharmacol 86: 1336–1345, 2020PubMed10.1111/bcp.14245)| false
BattistoniA, TocciG, ColucciaR, BurnierM, RuilopeLM, VolpeM: Antihypertensive drugs and the risk of cancer: A critical review of available evidence and perspective. J Hypertens38: 1005–1015, 2020PubMed
BattistoniA, TocciG, ColucciaR, BurnierM, RuilopeLM, VolpeM: Antihypertensive drugs and the risk of cancer: A critical review of available evidence and perspective. J Hypertens 38: 1005–1015, 2020PubMed10.1097/HJH.0000000000002379)| false
ChowCK, AtkinsER, HillisGS, NelsonMR, ReidCM, SchlaichMP, et al.; QUARTET Investigators: Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): A phase 3, randomised, double-blind, active-controlled trial. Lancet398: 1043–1052, 2021PubMed
ChowCK, AtkinsER, HillisGS, NelsonMR, ReidCM, SchlaichMP, ; QUARTET Investigators: Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): A phase 3, randomised, double-blind, active-controlled trial. Lancet 398: 1043–1052, 2021PubMed10.1016/S0140-6736(21)01922-X)| false
ZheutlinAR, DeringtonCG, KingJB, BerchieRO, HerrickJS, DixonDL, et al.: Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018. Am Heart J248: 150–159, 2022PubMed
ZheutlinAR, DeringtonCG, KingJB, BerchieRO, HerrickJS, DixonDL, : Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018. Am Heart J 248: 150–159, 2022PubMed10.1016/j.ahj.2021.10.184)| false
MuntnerP, HardyST, FineLJ, JaegerBC, WozniakG, LevitanEB, et al.: Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA324: 1190–1200, 2020PubMed
MuntnerP, HardyST, FineLJ, JaegerBC, WozniakG, LevitanEB, : Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA 324: 1190–1200, 2020PubMed10.1001/jama.2020.14545)| false
BellowsBK, Ruiz-NegrónN, Bibbins-DomingoK, KingJB, PletcherMJ, MoranAE, et al.: Clinic-based strategies to reach United States million hearts 2022 blood pressure control goals. Circ Cardiovasc Qual Outcomes12: e005624, 2019PubMed
BellowsBK, Ruiz-NegrónN, Bibbins-DomingoK, KingJB, PletcherMJ, MoranAE, : Clinic-based strategies to reach United States million hearts 2022 blood pressure control goals. Circ Cardiovasc Qual Outcomes 12: e005624, 2019PubMed10.1161/CIRCOUTCOMES.118.005624)| false
GnanenthiranSR, BorghiC, BurgerD, CaramelliB, CharcharF, ChirinosJA, CohenJB, et al.: Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension. J Am Heart Assoc24: e026143, 2022PubMed
GnanenthiranSR, BorghiC, BurgerD, CaramelliB, CharcharF, ChirinosJA, CohenJB, : Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension. J Am Heart Assoc 24: e026143, 2022PubMed10.1161/JAHA.122.026143)| false
WysockiJ, LoresE, YeM, SolerMJ, BatlleD: Kidney and lung ACE2 expression after an ACE inhibitor or an Ang II receptor blocker: Implications for COVID-19. J Am Soc Nephrol31: 1941–1943, 2020PubMed
WysockiJ, LoresE, YeM, SolerMJ, BatlleD: Kidney and lung ACE2 expression after an ACE inhibitor or an Ang II receptor blocker: Implications for COVID-19. J Am Soc Nephrol 31: 1941–1943, 2020PubMed10.1681/ASN.2020050667)| false
CareyRM, WheltonPK: Evidence for the universal blood pressure goal of <130/80 mm Hg is strong: Controversies in hypertension–Pro side of the argument. Hypertension76: 1384–1390, 2020PubMed
CareyRM, WheltonPK: Evidence for the universal blood pressure goal of <130/80 mm Hg is strong: Controversies in hypertension–Pro side of the argument. Hypertension 76: 1384–1390, 2020PubMed10.1161/HYPERTENSIONAHA.120.14647)| false
KaulS: Evidence for the universal blood pressure goal of <130/80 mm Hg is strong: Controversies in hypertension - con side of the argument. Hypertension76: 1391–1399, 2020PubMed
KaulS: Evidence for the universal blood pressure goal of <130/80 mm Hg is strong: Controversies in hypertension - con side of the argument. Hypertension 76: 1391–1399, 2020PubMed10.1161/HYPERTENSIONAHA.120.14648)| false
TownsendRR, ChangTI, CohenDL, CushmanWC, EvansGW, GlasserSP, et al.; SPRINT Study Research Group: Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. J Am Soc Hypertens10: 847–856, 2016PubMed
TownsendRR, ChangTI, CohenDL, CushmanWC, EvansGW, GlasserSP, ; SPRINT Study Research Group: Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. J Am Soc Hypertens 10: 847–856, 2016PubMed10.1016/j.jash.2016.08.005)| false
MargolisKL, DehmerSP, Sperl-HillenJ, O’ConnorPJ, AscheSE, BergdallAR, et al.: Cardiovascular events and costs with home blood pressure telemonitoring and pharmacist management for uncontrolled hypertension. Hypertension76: 1097–1103, 2020PubMed
OmboniS, McManusRJ, BosworthHB, ChappellLC, GreenBB, KarioK, et al.: Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: An international expert position paper. Hypertension76: 1368–1383, 2020PubMed
OmboniS, McManusRJ, BosworthHB, ChappellLC, GreenBB, KarioK, : Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: An international expert position paper. Hypertension 76: 1368–1383, 2020PubMed10.1161/HYPERTENSIONAHA.120.15873)| false
HermidaRC, AyalaDE, MojónA, FernándezJR: Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study. Chronobiol Int27: 1629–1651, 2010PubMed
HermidaRC, AyalaDE, MojónA, FernándezJR: Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study. Chronobiol Int 27: 1629–1651, 2010PubMed10.3109/07420528.2010.510230)| false
TurgeonRD, AlthouseAD, CohenJB, EnacheB, HogeneschJB, JohansenME, et al.: Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: Controversies in hypertension–Con side of the argument. Hypertension78: 871–878, 2021PubMed
TurgeonRD, AlthouseAD, CohenJB, EnacheB, HogeneschJB, JohansenME, : Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: Controversies in hypertension–Con side of the argument. Hypertension 78: 871–878, 2021PubMed10.1161/HYPERTENSIONAHA.121.16501)| false
JonesDW, WheltonPK, AllenN, Clark3rdD, GiddingSS, MuntnerP, et al.; American Heart Association Council on Hypertension; Council on the Kidney in Cardiovascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; and Stroke Council: Management of stage 1 hypertension in adults with a low 10-year risk for cardiovascular disease: Filling a guidance gap: A scientific statement from the American Heart Association. Hypertension77: e58–e67, 2021PubMed
JonesDW, WheltonPK, AllenN, Clark3rdD, GiddingSS, MuntnerP, ; American Heart Association Council on Hypertension; Council on the Kidney in Cardiovascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; and Stroke Council: Management of stage 1 hypertension in adults with a low 10-year risk for cardiovascular disease: Filling a guidance gap: A scientific statement from the American Heart Association. Hypertension 77: e58–e67, 2021PubMed10.1161/HYP.0000000000000195)| false
Blood Pressure Lowering Treatment Trialists’ Collaboration: Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: An individual participant-level data meta-analysis. Lancet397: 1625–1636, 2021PubMed
Blood Pressure Lowering Treatment Trialists’ Collaboration: Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: An individual participant-level data meta-analysis. Lancet 397: 1625–1636, 2021PubMed10.1016/S0140-6736(21)00590-0)| false
Blood Pressure Lowering Treatment Trialists’ Collaboration: Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: An individual participant-level data meta-analysis. Lancet398: 1053–1064, 2021PubMed
Blood Pressure Lowering Treatment Trialists’ Collaboration: Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: An individual participant-level data meta-analysis. Lancet 398: 1053–1064, 2021PubMed10.1016/S0140-6736(21)01921-8)| false
HallME, CohenJB, ArdJD, EganBM, HallJE, LavieCJ, et al.; American Heart Association Council on Hypertension; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; and Stroke Council: Weight-loss strategies for prevention and treatment of hypertension: A scientific statement from the American Heart Association. Hypertension78: e38–e50, 2021PubMed
HallME, CohenJB, ArdJD, EganBM, HallJE, LavieCJ, ; American Heart Association Council on Hypertension; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; and Stroke Council: Weight-loss strategies for prevention and treatment of hypertension: A scientific statement from the American Heart Association. Hypertension 78: e38–e50, 2021PubMed10.1161/HYP.0000000000000202)| false
BöhmM, KarioK, KandzariDE, MahfoudF, WeberMA, SchmiederRE, et al.; SPYRAL HTN-OFF MED Pivotal Investigators: Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): A multicentre, randomised, sham-controlled trial. Lancet395: 1444–1451, 2020PubMed
